Photo from Dana-Farber Cancer Institute/LinkedIn
Jul 4, 2024, 16:09
A deep dive into immune responses to cancer vaccines plus immunotherapy – Dana-Farber Cancer Institute
“David Reardon, MD, is doing a deep dive into the immune responses of patients who are receiving cancer vaccines plus immunotherapy.
For patients with glioblastoma, timing is everything. The average time to recurrence after surgery is six or seven months. It takes several months to create a personalized vaccine. Once the vaccine is given to the patient, it takes at least one to two months for the immune system to begin mounting an immune response.
‘We’re literally in a race against the tumor’, says Reardon.
Learn about how Reardon and other Dana-Farber researchers are working to advance personal cancer vaccines.”
Further infromation.
Source:
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18
Dec 21, 2024, 11:12
Dec 21, 2024, 11:06
Dec 21, 2024, 10:38